| Price | Rs 389.00 |
| ZEME fair value | Rs 368.56 |
| Discount to fair value | -5.3% |
| Smart-money phase | Fully Loaded |
| Confidence score | 57/100 |
| RSI (14) | 47.2 |
| P/E | 18.0 |
| ROE | —% |
| Dividend yield | 1.0% |
| 52-week range | Rs 299.95 – Rs 454.59 |
| Sector | Pharmaceuticals |
| Shariah-compliant | Yes ☪ |
FEROZ (Ferozsons Laboratories Limited) trades at Rs 389.00 on the Pakistan Stock Exchange, in the Fully Loaded smart-money phase — accumulated. ZEME's model puts fair value near Rs 368.56, making it about 5.3% overvalued. Smart money has fully loaded the position — a mature bullish setup, often before a markup.
ZEME AI reads FEROZ through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.
Constructive — ZEME sees smart-money accumulation; check the entry vs the load zone. Smart money has fully loaded the position — a mature bullish setup, often before a markup. As of 20 Jul 2026, FEROZ is in the Fully Loaded phase with a ZEME confidence score of 57/100.
ZEME estimates FEROZ's fair value at about Rs 368.56, versus a market price of Rs 389.00 — roughly 5.3% overvalued.
FEROZ is currently in the Fully Loaded phase. Smart money has fully loaded the position — a mature bullish setup, often before a markup.
Data updated 20 Jul 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.